#news #biotech Anthera’s Sollpura canned after phase 3 flop, shares plunge

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Anthera’s Sollpura canned after phase 3 flop, shares plunge .Anthera has seen its fair share of setbacks over the years, and today that tally only got longer as it cut loose a failed late-stage Lilly cast-off, Sollpura (liprotamase), and now seeks those dreaded “strategic alternatives.”

from FierceBiotech: Biotech http://ift.tt/2p2kV90